CLDN8 and breast carcinoma: These data validate the foundational theory that high CLDN8 expression signifies endocrine sensitivity but may also indicate resistance to chemotherapy, especially in a pre-surgical setting, potentially serving as a pivotal factor in tailoring personalized treatment strategies and enhancing therapeutic efficacy for patients with breast cancer.